β-Catenin mutations are frequent in hepatocellular carcinomas but absent in adenomas induced by diethylnitrosamine in B6C3F1 mice

Cancer Research

Volumn 59, Issue 8, 1999, Pages 1830-1833

  Ogawa, Katsuhiro ^a   Yamada, Yoshihisa ^a   Kishibe, Kan ^a   Ishizaki, Kenichi ^a   Tokusashi, Yoshihiko ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASEIN KINASE I;

ADENOMA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ENZYME PHOSPHORYLATION; GENE MUTATION; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOMA; ANIMALS; BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CYTOSKELETAL PROTEINS; DIETHYLNITROSAMINE; EXONS; FEMALE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS, EXPERIMENTAL; MALE; MICE; MICE, INBRED C57BL; MUTATION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANS-ACTIVATORS;

EID: 0033561676     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Morin, P. J., Sparks, A. B., Korinek, V., Barker, N., Clevers, H., Vogelstein, B., and Kinzler, K. W. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science (Washington DC), 275: 1787-1790, 1997.
2. Rubinfeld, B., Robbins, P., El-Gamil, M., Albert, I., Porfiri, E., and Polakis, P. Stabilization of β-catenin by genetic defects in melanoma cell lines. Science (Washington DC), 275: 1790-1792, 1997.
3. Zuwawel, B. H., Chiappa, S. A., Allen, C., and Raffel, C. Sporadic medulloblastomas contain oncogenic β-catenin mutations. Cancer Res., 58: 869-899, 1998.
4. Palacios, J., and Gamallo, C. Mutations in the β-catenin gene (CTNNBI) in endometrial ovarian carcinomas. Cancer Res., 58: 1344-1347, 1998.
5. Voeller, H. J., Truica, C. I., and Gelmann, E. P. β-Catenin mutations in human prostate cancer. Cancer Res., 58: 2520-2523, 1998.
6. Fukuchi, T., Sakamoto, M., Tsuda, H., Maruyama, K., Nozawa, S., and Hirohashi, S. β-Catenin mutations in carcinoma of the uterine endometrium. Cancer Res., 58: 3526-3528, 1998.
7. Miyoshi, Y., Iwao, K., Nagasawa, Y., Aihara, T., Sasaki, Y., Murata, M., Shimano, T., and Nakamura, Y. Activation of the β-catenin gene in primary hepatocelluar carcinomas by somatic alterations involving exon 3. Cancer Res., 58: 2524-2527, 1998.
8. Takahashi, M., Fukuda, K., Sugimura, T., and Wakabayashi, K. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors. Cancer Res., 58: 42-46, 1998.
9. Coste, A. D. L., Romagnolo, B., Billuart, P., Renard, C. A., Buendia, M. A., Soubrane, O., Fahre, M., Chelly, J., Beldjord, C., Kahn, A., and Perret, C. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. USA, 95: 8847-8851, 1998.
10. Pennisi, P. How a growth control path takes a wrong turn to cancer. Science (Washington DC), 281: 1438-1441, 1998.
11. Rubinfeld, B., Albert, I., Porfiri, E., Fiol, C., Munemitsu, S., and Polakis, P. Binding of GSK3 β to the APC- β-catenin complex and regulation of complex assembly. Science (Washington DC), 272: 1023-1026, 1996.
12. Aberle, H., Bauer, A., Stappert, J., Kispert, A., and Kemler, R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J., 16: 3797-3804, 1997.
13. Orford, K., Cockett, C., Jensen, J. P., Weissmann, A. M., and Byers, S. W. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J. Biol. Chem., 272: 24735-24738, 1997.
14. Hart, M. J., de los Santos, R., Albert, I. N., Rubinfeld, B., and Polakis, P. Down-regulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3 β. Curr. Biol., 8: 573-581, 1998.
15. Papkoff, J., Rubinfeld, B., Schryver, B., and Polakis, P. Wnt-1 regulates free pools of catenins and stabilize APC-catenin complexes. Mol. Cell. Biol., 16: 2128-2134, 1996.
16. -/- colon carcinoma. Science (Washington DC), 275: 1784-1787, 1997.
17. Molenaar, M., Wetering, M. V. D., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destree, O., and Clevers, H. XTcf-3 transcription factor mediates β-catenin-induced axis formation in xenopus embryos. Cell, 86: 391-399, 1996.
18. Beherens, J., Kries, J. P. V., Kuhl, U., Bruhn, L., Wedlich, D., Grosschedl, R., and Birchmeier, W. Functional interaction of β-catenin with the transcription factor LEFI. Nature (Lond.), 382: 638-642, 1996.
19. He, T. C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., Costa, L. T. D., Morin, P. J., Vogelstein, B., and Kinzler, K. W. Identification of c-MYC as a target of the APC pathway. Science (Washington DC), 281: 1509-1512, 1998.
20. Tabor, E. Tumor suppressor genes, growth factor genes, and oncogenes in hepatitis B virus-associated hepatocellular carcinoma. J. Med. Virol., 42: 357-365, 1994.
21. Vesselinovitch, S. D., and Mihailovich, N. Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res., 43: 4253-4259, 1983.
22. Maronpot, R. R., Fox, T., and Malarley, D. E. Mutations in the ras oncogene; clues to etiology and molecular pathology of mouse liver tumors. Toxicology, 101: 125-156, 1995.
23. Frith, C. H., and Ward, J. M. A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J. Environ. Pathol. Toxicol., 3: 329-351, 1979.
24. Butz, S., Stappert, J., Weissig, H., and Kemler, R. Plakoglobin and β-catenin: distinct but closely related. Science (Washington DC), 257: 1142-1144, 1992.
25. Moser, A. R., Luongo, C., Gould, K. A., McNeley, M. K., Shoemaker, A. R., and Dove, W. F. ApcMin: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer, 31A: 1061-1604, 1995.
26. Piao, Z., Kim, H., Jeon, B. K., Lee, W. J., and Park, C. Relationship between loss of heterozygosity of tumor suppressor genes and histological differentiation in hepatocellular carcinomas. Cancer (Phila.), 80: 865-872, 1997.
27. Yost, C., Farr, G. H. T., Pierce, S. B., Ferkey, D. M., Chen, M. M., and Kimelman, D. GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell, 93: 1031-1041, 1998.
28. Novak, A., Hsu, S. C., Leung-Hagesteijn, C., Radeva, G., Popkoff, J., Montesano, R., Roskelley, C., Grosschedel, R., and Dedhar, S. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and β-catenin signaling pathways. Proc. Natl. Acad. Sci. USA, 95: 4374-4379, 1998.
29. Buchmann, A., Mahr, J., Bauer-Hofmann, R., and Schwarz, M. Mutations at codon 61 of the Ha-ras proto-oncogene in precancerous liver lesions of the B6C3F1 mice. Mol. Carcinog., 2: 121-125, 1989.
30. Romach, E. H., Goldswarthy, T. L., Maronpot, R. R., and Fox, R. R. Altered gene expression in spontaneous hepatocellular carcinoma from male B6C3F1 mice. Mol. Carcinog., 19: 31-38, 1997.
31. Robinson, W. S. Molecular events in the pathogenesis of hepadnavirus-associated hepatocellular carcinomas. Ann. Rev. Med., 45: 297-323, 1994.
32. Wink, D. A., Kasprzak, K. S., Maragon, C. M., Elespuru, R. K., Misra, M., Dunams, T. M., Cebula, T. A., Koch, W. H., Andrews, A. W., Allen, J. S., and Keefer, L. K. DNA deaminating ability and genotoxicity of nitric oxide and its progenitors. Science (Washington DC), 254: 1001-1003, 1991.